Concentrations of Insulin-like Growth Factors and Insulin-like Growth Factor-Binding Proteins and Respective Gene Expressions in Children before and after Hematopoietic Stem Cell Transplantation.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
30 Nov 2021
Historique:
received: 17 09 2021
revised: 24 11 2021
accepted: 28 11 2021
entrez: 28 12 2021
pubmed: 29 12 2021
medline: 22 1 2022
Statut: epublish

Résumé

Insulin-like growth factors (IGF-1 and IGF-2) and insulin-like growth factor-binding proteins (IGFBP-1 to -7) are involved in the regulation of cell proliferation and differentiation and may be associated with various metabolic parameters. The aim of our study was to compare levels of IGFs and IGFBPs and the expressions of their genes in children before and after hematopoietic stem cell transplantation (HSCT) to assess their potential as markers of late metabolic complications of HSCT. We also conducted additional comparisons with healthy controls and of correlations of IGF and IGFBP levels with anthropometric and biochemical parameters. We analyzed 19 children treated with HSCT and 21 healthy controls. We found no significant differences in the levels of IGFs and IGFBPs and expressions of their genes before and after HSCT, while IGF and IGFBP levels were significantly lower in children treated with HSCT compared with controls. We conclude that our results did not reveal significant differences between the levels of IGFs and IGFBPs before and after HSCT, which would make them obvious candidates for markers of late complications of the procedure in children. However, due to the very low number of patients this conclusion must be taken with caution and may be altered by further research.

Identifiants

pubmed: 34959885
pii: nu13124333
doi: 10.3390/nu13124333
pmc: PMC8709367
pii:
doi:

Substances chimiques

Biomarkers 0
IGF1 protein, human 0
IGF2 protein, human 0
Insulin-Like Growth Factor Binding Proteins 0
Insulin-Like Growth Factor I 67763-96-6
Insulin-Like Growth Factor II 67763-97-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Center
ID : NN 407 198737
Organisme : Jagiellonian University
ID : K/ZDS/003825

Références

Endocrinology. 2009 Oct;150(10):4575-82
pubmed: 19608653
Front Immunol. 2020 Apr 21;11:673
pubmed: 32373125
Bone Marrow Transplant. 2020 Oct;55(10):1906-1917
pubmed: 32346079
J Clin Endocrinol Metab. 2000 Nov;85(11):4087-92
pubmed: 11095437
Biol Blood Marrow Transplant. 2017 Feb;23(2):201-210
pubmed: 27590105
Clin Biochem. 2008 Aug;41(12):937-42
pubmed: 18503765
Mol Metab. 2021 Oct;52:101245
pubmed: 33962049
Prog Growth Factor Res. 1991;3(4):243-66
pubmed: 1725860
Biol Blood Marrow Transplant. 2016 Jul;22(7):1159-1166
pubmed: 27013015
Nutrients. 2021 Jul 15;13(7):
pubmed: 34371941
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S96-9
pubmed: 10997620
PLoS One. 2008 Jul 02;3(7):e2578
pubmed: 18596909
Pediatr Transplant. 2012 Dec;16(8):872-8
pubmed: 23131056
J Trop Pediatr. 1999 Dec;45(6):327-37
pubmed: 10667001
Biol Blood Marrow Transplant. 2014 Jun;20(6):794-800
pubmed: 24565992
Contemp Oncol (Pozn). 2018;22(4):223-228
pubmed: 30783385
Hum Mol Genet. 2008 May 15;17(10):1457-64
pubmed: 18250100
Acta Endocrinol (Copenh). 1988 Jul;118(3):374-80
pubmed: 2455951
J Clin Invest. 1996 Dec 1;98(11):2612-5
pubmed: 8958225
Cells. 2019 Aug 14;8(8):
pubmed: 31416218
Ann Intern Med. 1992 May 15;116(10):854-62
pubmed: 1373590
Bone Marrow Transplant. 2003 Aug;32(4):411-5
pubmed: 12900778
Front Immunol. 2020 Jul 24;11:1646
pubmed: 32793242
Endocr J. 1996 Oct;43 Suppl:S43-8
pubmed: 9076341
Biol Blood Marrow Transplant. 2010 Aug;16(8):1138-44
pubmed: 20197101
Cancers (Basel). 2021 Sep 09;13(18):
pubmed: 34572762
Front Immunol. 2021 Jan 06;11:535890
pubmed: 33488571
Mol Metab. 2019 Jan;19:86-96
pubmed: 30392760
Eur J Pediatr. 1996 Feb;155(2):81-6
pubmed: 8775218
Bone Marrow Transplant. 2017 Jun;52(6):863-869
pubmed: 28436969
Pediatr Res. 2010 Apr;67(4):340-4
pubmed: 20057340
Transplant Cell Ther. 2021 Feb;27(2):180.e1-180.e8
pubmed: 33830034
Diabetes. 2003 Jun;52(6):1403-8
pubmed: 12765950
Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1098-E1107
pubmed: 30040480
Endocr Rev. 1995 Feb;16(1):3-34
pubmed: 7758431
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
Bone Marrow Transplant. 2017 Apr;52(4):506-513
pubmed: 28067888

Auteurs

Wojciech Strojny (W)

Department of Pediatric Oncology and Hematology, University Children's Hospital of Krakow, 30-663 Krakow, Poland.

Wojciech Czogała (W)

Department of Pediatric Oncology and Hematology, University Children's Hospital of Krakow, 30-663 Krakow, Poland.
Department of Pediatric Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Przemysław Tomasik (P)

Department of Clinical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Mirosław Bik-Multanowski (M)

Department of Medical Genetics, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Małgorzata Wójcik (M)

Department of Pediatric and Adolescent Endocrinology, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Klaudia Miklusiak (K)

Student Scientific Group of Pediatric Oncology and Hematology, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Karol Miklusiak (K)

Student Scientific Group of Pediatric Oncology and Hematology, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Przemysław Hałubiec (P)

Student Scientific Group of Pediatric Oncology and Hematology, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Szymon Skoczeń (S)

Department of Pediatric Oncology and Hematology, University Children's Hospital of Krakow, 30-663 Krakow, Poland.
Department of Pediatric Oncology and Hematology, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH